Daily Market Report: Thu, 12 Mar 2026 15:30 UTC → Fri, 13 Mar 2026 15:30 UTC

Analyzed 832 news items.

Global markets experienced significant volatility over the past 24 hours, primarily driven by escalating geopolitical tensions in the Middle East, particularly concerns around the Iran conflict and its impact on oil supply. This led to a sharp rise in crude oil prices, with Brent breaching $100 a barrel and briefly touching $115, consequently pushing up gasoline prices to $3.54/gallon nationally. The S&P 500 reacted negatively, falling to its lowest level since November, erasing all 2026 gains, and breaking key support at 6,700, entering stagflationary concerns. Futures markets are indicating further cautious trading at the open, with S&P 500 futures showing minor pre-market gains despite individual stock pressures. Technology and growth stocks were particularly hit by rising yields and reassessments of inflated valuations, while energy and defense sectors saw a boost. The market is keenly watching for further developments in the Middle East and upcoming economic data releases, which could provide direction amidst the current uncertainty. Major indices closed down yesterday, with the S&P 500 down 1.5%, Dow Jones Industrial Average down 0.8%, and Nasdaq Composite down 2.1%.

Key Events

• Middle East Geopolitical Tensions Escalate, Driving Oil Prices Higher — Brent crude oil soared past $100 a barrel and briefly hit $115, causing a 6% drop in Royal Caribbean Cruises (RCL) and a 6.23% decline in Shake Shack (SHAK) shares due to increased energy costs. Exxon Mobil (XOM) and Occidental Petroleum (OXY) saw significant gains of 28% and 4.53% respectively due to rising oil prices. The S&P 500 fell to its lowest since November, erasing all 2026 gains.
• Middle East Conflict Ripples Across Global Commodity Markets — BMO warns of disruptions in oil, fertilizers, and chemicals. CF Industries (CF) shares surged 7.58% to an all-time high amidst concerns over fertilizer supply and accusations of price gouging from Senator Josh Hawley after urea prices rose 32%.
• Adobe CEO Shantanu Narayen to Step Down After 18 Years, Stock Drops — Adobe (ADBE) shares fell 7.68% in premarket trading. The company also faces a trademark infringement lawsuit over its 'Foundry' AI tool and mixed Q4 earnings. Despite record Q1 FY2026 revenue of $6.40 billion (up 12% YoY), the long-time CEO's departure signals uncertainty.
• Ulta Beauty Issues Weak 2026 Guidance, Shares Slide — Ulta Beauty's shares dropped after forecasting a slower growth rate of 6% to 7% for fiscal year 2026 sales, despite beating Q4 earnings expectations with $8.01 EPS and $3.898 billion in sales. This raises concerns about consumer spending on discretionary items.
• Nvidia Dumps Applied Digital Stake, Bets Big on AI Infrastructure — Nvidia sold its entire 7.7 million share stake (~$177 million) in Applied Digital. Concurrently, Nvidia committed over $36 billion to AI partners and suppliers in the last month, including a $30 billion commitment to AI infrastructure.
• Electric Vehicle Market Faces Headwinds, U.S. Registrations Decline — U.S. EV registrations fell 0.4% year-over-year in 2025, the first decline in a decade. Tesla (TSLA) stock has pulled back significantly from early 2026 highs, deepening concerns for EV investors.
• Applied Materials Raises Dividend by 15% amid AI Memory Partnerships — Applied Materials (AMAT) increased its quarterly cash dividend by 15% to $0.53 per share, marking the ninth consecutive increase. This follows a long-term R&D partnership with SK hynix focused on next-generation AI memory technologies, and continued strong demand for specialized semiconductor equipment.
• Dollar General Stock Dips Despite Q4 Earnings Beat, Weak 2026 Outlook — Dollar General (DG) stock fell 6% despite beating Q4 earnings expectations with 4.3% same-store sales growth and 5.9% net sales increase to $10.9 billion. The decline is attributed to a weaker-than-expected outlook for fiscal year 2026, signaling potential challenges for discount retailers.
• Immutep Shares Plunge 90% After Lung Cancer Drug Trial Failure — Immutep (ASX: IMM) stock plummeted 90% after discontinuing its Phase III trial for 'efti' (eftilagimod alfa) in non-small cell lung cancer due to futility. This highlights the high-risk nature of biotech drug development.
• Kroger Shares Hit New High on Zepbound Availability and Analyst Optimism — Kroger's (KR) stock reached a new 52-week high of $75.95 due to strong performance and analyst price target increases. The company's pharmacies will now offer Eli Lilly's Zepbound® KwikPen, expanding access to weight-loss medication and potentially boosting pharmacy sales.

Sector Analysis

• Energy
• Technology (Semiconductors & AI)
• Retail & Consumer Discretionary
• Biotechnology & Pharmaceuticals
• Financials
• Manufacturing & Industrials
• REITs & Real Estate

Risk Factors

Opportunities

• Long Energy Sector: Oil & Gas Producers and Refiners
• Defense Sector Expansion
• AI Infrastructure and Specialized Semiconductor Equipment Providers
• Value-Oriented Retailers with Strong Performance (e.g., Kroger leveraging Zepbound)
• Biotech Companies with Positive Clinical Trial Readouts and Regulatory Milestones
• Domestic-Focused Industrials and Materials

Economic Outlook

Today's economic calendar is light, but focus remains on geopolitical developments and any ripple effects on commodity markets. No major economic data releases are scheduled before market open. Federal Reserve speakers or central bank decisions are not expected today. Geopolitical tensions in the Middle East, particularly around the Iran conflict, remain the primary market driver, with potential for further oil price volatility. Investors will also be watching for any further earnings reports or significant corporate announcements that could shift sentiment.

Recommendations

This is an AI-generated market analysis published by CausifyMarket for informational purposes only. Not financial advice.